Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Researchers identified genes in scalp hair follicles that may affect hair traits and hair loss.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Spexin levels are lower in PCOS patients and linked to metabolic and hormonal issues.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Fetal environments contain various chemicals that may disrupt hormones.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

A woman with a rare hormone resistance condition also had missing teeth and hair loss, which might be new symptoms of her genetic disorder.

The HR protein's role as a repressor is essential for controlling hair growth.

Cholesterol transport in hair follicles decreases from growth to regression phase.

The substances improved hair regrowth and protected hair cells in humans and mice.

Abnormal growth factor metabolism may link psoriasis and metabolic syndrome, and obesity can affect psoriasis treatment effectiveness.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Androgens can both increase and decrease hair growth in different parts of the body.